Archive for March 2017

The 5 Largest Drug Lawsuit Settlements in U.S. History

u.s. drug lawsuit settlements

Creating new medications is big business, but it can also be costly if emerging drugs and medical devices are rushed to market without a full explanation of the side effects. Many name brand pharmaceutical companies have found this out the hard way, being on the receiving end of the largest drug lawsuit settlements in American…

Read More

Adverse Drug Reactions Hit Record Levels

adverse drug reports

The negative impact of drug side effects has hit record levels in recent years, according to the latest data released by the U.S. Food and Drug Administration (FDA). Worse still, the analysis also shows a fivefold increase in adverse drug reactions over the past 12 years.  Back in 2004, there were 206,000 reports filed, covering side-effects…

Read More

Proposed Bill Could "Straight Jacket" Class Actions

house class action lawsuit bill

A new bill proposed by lawmakers threatens to stifle class actions and limit the few remaining protections defending consumers from large corporations, according to its critics. The Fairness in Class Action Litigation Act narrowly passed through the House of Representatives last week. It is a revised version of a less ambitious bill that failed to…

Read More

Class Action Lawsuit Against Transvaginal Mesh

canada lawsuit against transvaginal mesh

February ended with a double-blow for Boston Scientific, manufacturers of the litigation-plagued transvaginal mesh. Not only did the company fail with an appeal to the U.S. Supreme Court regarding a different medical device, it also found out it would be facing another lawsuit against transvaginal mesh in Canada. On the U.S. side, the decision went against…

Read More

A Bipartisan Bill? Drug Prices Unite U.S. Politicians


In a political environment more charged than any other time in recent memory, issues that everyone can agree on are few and far between. Even against that divisive backdrop, however, there seems to be one problem that all parties want to tackle as soon as possible: inflated drug prices in the U.S.  As February came…

Read More